Dr Mohit Bhutani
Dr. Mohit Bhutani’s achievements in the clinical, research and educational aspects of respiratory diseases have contributed to his recognition as a leading member of the respiratory community. Dr. Bhutani completed his medical degree and core internal medicine residency at the University of Saskatchewan, followed by fellowships in pulmonary and critical care medicine at the University of Western Ontario in 2004. He joined the Faculty of Medicine & Dentistry at the University of Alberta as assistant professor in the Division of Pulmonary Medicine in 2005. He was promoted to associate professor of medicine in 2011 and professor in 2019.
Dr. Bhutani has been an active member of the Division of Pulmonary Medicine. He was associate program director of the Pulmonary Fellowship Program from 2005-2017. He is the director of the Asthma and COPD clinics and a member of the executive of the Alberta Research Center. Provincially, he has been involved with the Alberta Health Services Respiratory Health Strategic Clinical Network since 2011 and, from 2014-2020, co-chaired the Airways Working Group of the Respiratory Health Strategic Clinical Network (RHSCN).The primary aim of the RHSCN is to improve and standardize the delivery of respiratory care to all patients in both urban and rural settings. Nationally, he chairs the Royal College of Physicians and Surgeons of Canada Adult Respiratory Examination Board and is the current past chair of Canadian Thoracic Society COPD Clinical Assembly. He was elected to the Canadian Thoracic Society Executive in June 2020.
His past leadership positions include that of chair of the Scientific Committee of the 2018 Canadian Respiratory Conference.
Dr. Bhutani’s research in COPD and asthma has garnered many provincial and national research awards and he has been involved in phase 2 and 3 clinical trials evaluating the effectiveness of new drug therapies. His endeavors have secured more than $2.4 million dollars in research funding to date. His research work has been published in high impact journals such as The Journal of Physiology, Lancet Respiratory Medicine, CHEST and New England Journal of Medicine. He has been one of the lead authors of the last 3 COPD guidelines, and is currently working on the 2022 CTS Pharmacotherapy Guidelines. As a result of his work, he has been asked to present at many conferences and accredited courses nationally and internationally. He is an ad hoc reviewer for the Canadian Journal of Respiratory, Critical Care and Sleep Medicine.